EVO Stock Summary and Trading Ideas (Evotec Se - American Depositary Shares Each Representing 1/2 Of One Ordinary Share | NASDAQ:EVO)

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Evotec Se - American Depositary Shares Each Representing 1/2 Of One Ordinary Share trades on the NASDAQ stock market under the symbol EVO.

As of December 19, 2025, EVO stock price climbed to $2.95 with 1,880,623 million shares trading.

EVO has a beta of 1.06, meaning it tends to be more sensitive to market movements. EVO has a correlation of 0.11 to the broad based SPY ETF.

EVO has a market cap of $1.05 billion. This is considered a Small Cap stock.

Last quarter Evotec Se - American Depositary Shares Each Representing 1/2 Of One Ordinary Share reported $192 million in Revenue and -$.14 earnings per share. This fell short of revenue expectation by $-46 million and met earnings estimates .

In the last 3 years, EVO traded as high as $13.49 and as low as $2.84.

The top ETF exchange traded funds that EVO belongs to (by Net Assets): IBB.

EVO has underperformed the market in the last year with a price return of -33.0% while the SPY ETF gained +18.1%. EVO has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -19.0% and -5.4%, respectively, while the SPY returned +2.8% and -0.5%, respectively.

EVO support price is $2.84 and resistance is $3.02 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EVO shares will trade within this expected range on the day.